PT-141 (Bremelanotide) Prescribed Online to Wisconsin Residents
PT-141 (Bremelanotide) is a melanocortin receptor agonist that enhances sexual desire and arousal through the central nervous system — not the vascular system. It is the first non-hormonal treatment for hypoactive sexual desire disorder approved by the FDA.
What Is PT-141 (Bremelanotide)?
PT-141 (Bremelanotide) is a melanocortin receptor agonist that enhances sexual desire and arousal through the central nervous system — not the vascular system. It is the first non-hormonal treatment for hypoactive sexual desire disorder approved by the FDA.
Benefits of PT-141 (Bremelanotide)
Works through the brain to enhance desire and arousal
Effective for both men and women
Addresses root causes of low libido rather than just physical response
FDA-approved active ingredient (Vyleesi for women)
Unique central mechanism distinct from PDE5 inhibitors
Wisconsin's hardworking people deserve healthcare that fits their lifestyle. From the breweries of Milwaukee to the government center of Madison, the manufacturing towns along Lake Michigan to the dairy farms of the Driftless Region, OmniRx Health serves all of America's Dairyland. Our telehealth platform understands Wisconsin values—no-nonsense, quality care delivered efficiently, whether you're in a major city or a small town.
Getting PT-141 (Bremelanotide) Prescribed in Wisconsin
Licensed in WI
OmniRx Health providers are licensed by the Wisconsin Medical Examining Board for comprehensive statewide telehealth services.
Pharmacy Delivery
Wisconsin pharmacies in Milwaukee, Madison, Green Bay, and throughout the state provide prescription services with reliable delivery.
Wisconsin has telehealth laws that support virtual care delivery while maintaining quality standards for patient safety.
Frequently Asked Questions About PT-141 (Bremelanotide)
Common questions from Wisconsin residents about PT-141 (Bremelanotide) treatment
Explore Related Sexual Wellness Options
Find the right treatment, in the right state, for you.